An insidious risk factor for cardiovascular disease: benign prostatic hyperplasia

Area of Science:

• Cardiovascular Medicine
• Urology
• Geriatrics

Background:

• Patients with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) exhibit a higher prevalence of cardiovascular disease (CVD) compared to the general population.
• Established CVD risk factors include age, hypertension, obesity, diabetes, and dyslipidemia, yet they don't fully explain CVD's complexity.
• Nontraditional risk factors like oxidative stress, inflammation, and genetic variations also contribute to CVD.

Discussion:

• BPH may act as an insidious risk factor for CVD through mechanisms like nocturia-induced sleep disturbances, blood pressure (BP) variability, and increased sympathetic activity.
• Potential links between BPH and increased BP, coronary ischemic heart disease, and other cardiovascular pathologies are being investigated.
• Focusing on BPH could offer novel diagnostic and therapeutic strategies for CVD.

Key Insights:

• BPH-related nocturia can disrupt sleep, leading to BP variability and heightened sympathetic nervous system activity, potentially contributing to CVD.
• The association between BPH and CVD warrants further investigation to elucidate underlying pathophysiological links.
• Patients with BPH/LUTS may represent a distinct population at increased risk for cardiovascular events.

Outlook:

• Prospective, randomized controlled studies are essential to definitively establish BPH as a CVD risk factor.
• Understanding the interplay between BPH and CVD could lead to integrated treatment approaches.
• Further research into the specific mechanisms linking BPH to cardiovascular conditions is crucial.